The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Oral Fluid Testing for Drugs of Abuse
Open accessAbstract
Background: Oral fluid (OF) is an exciting alternative matrix for monitoring drugs of abuse in workplace, clinical toxicology, criminal justice, and driving under the influence of drugs (DUID) programs. During the last 5 years, scientific and technological advances in OF collection, point-of-collection testing devices, and screening and confirmation methods were achieved. Guidelines were proposed for workplace OF testing by the Substance Abuse and Mental Health Services Administration, DUID testing by the European Union’s Driving under the Influence of Drugs, Alcohol and Medicines (DRUID) program, and standardization of DUID research. Although OF testing is now commonplace in many monitoring programs, the greatest current limitation is the scarcity of controlled drug administration studies available to guide interpretation. Content: This review outlines OF testing advantages and limitations, and the progress in OF that has occurred during the last 5 years in collection, screening, confirmation, and interpretation of cannabinoids, opioids, amphetamines, cocaine, and benzodiazepines. We examine controlled drug administration studies, immunoassay and chromatographic methods, collection devices, point-of-collection testing device performance, and recent applications of OF testing. Summary: Substance Abuse and Mental Health Services Administration approval of OF testing was delayed because questions about drug OF disposition were not yet resolved, and collection device performance and testing assays required improvement. Here, we document the many advances achieved in the use of OF. Additional research is needed to identify new biomarkers, determine drug detection windows, characterize OF adulteration techniques, and evaluate analyte stability. Nevertheless, there is no doubt that OF offers multiple advantages as an alternative matrix for drug monitoring and has an important role in DUID, treatment, workplace, and criminal justice programs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The rate of diffusion is affected by several factors including lipophilicity of the drug, salivary pH, pKa, molecular size, un-ionized free drug blood concentration and membrane characteristics (8–11).”
From Recommendations for Toxicological Investigation of Drug-Impaired Driving and Motor Vehicle Fatalities—2021 Update (2021) · cites this paper as [8]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recent developments within the field of forensic toxicology include increased interest in the use of oral fluid as a specimen for drug detection in impaired driving cases (8).”
From Recommendations for Toxicological Investigation of Drug-Impaired Driving and Motor Vehicle Fatalities—2021 Update (2021) · cites this paper as [8]
The cited source says what the claim attributes to it.
In the citing paper
“Drug deposition into oral fluid is via passive diffusion of un-ionized free drug from the blood through the salivary glands and ion trapping of basic drugs in the oral cavity.”
From Recommendations for Toxicological Investigation of Drug-Impaired Driving and Motor Vehicle Fatalities—2021 Update (2021) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dams, R., Huestis, M. A., Lambert, W. E., & Murphy, C. M. (2003) · Journal of the American Society for Mass Spectrometry · doi:10.1016/s1044-0305(03)00574-9 · Cited by 601
Self-citationRamaekers, J. G., Moeller, M. R., van Ruitenbeek, P., Theunissen, E. L., Schneider, E., & Kauert, G. F. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.03.015 · Cited by 290
Schepers, R. J., Oyler, J. M., Joseph, R. E., Cone, E. J., Moolchan, E. T., & Huestis, M. A. (2003) · Clinical Chemistry · doi:10.1373/49.1.121 · Cited by 259
Self-citationOral fluid collection: the neglected variable in oral fluid testing
Crouch, D. J. (2005) · Forensic Science International · doi:10.1016/j.forsciint.2005.02.028 · Cited by 228
Niedbala, R. S., Kardos, K. W., Fritch, D., Kardos, S., Fries, T., Waga, J., Robb, J. T., & Cone, E. J. (2001) · Journal of Analytical Toxicology · doi:10.1093/jat/25.5.289 · Cited by 218
Bush, D. M. (2007) · Forensic Science International · doi:10.1016/j.forsciint.2007.03.008 · Cited by 210
Huestis, M. A., & Cone, E. J. (2004) · Journal of Analytical Toxicology · doi:10.1093/jat/28.6.394 · Cited by 208
Self-citationThe role of alternative specimens in toxicological analysis
Gallardo, E., & Queiroz, J. A. (2008) · Biomedical Chromatography · doi:10.1002/bmc.1009 · Cited by 207
Interpretation of Oral Fluid Tests for Drugs of Abuse
Cone, E. J., & Huestis, M. A. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1384.037 · Cited by 200
Self-citationCone, E. J. (1990) · Journal of Analytical Toxicology · doi:10.1093/jat/14.1.1 · Cited by 189
Flagged first, then by citations
Research works printed but not linked: 11
- 2004, Clin Chem Lab Med, 42, 1273
- 2004, Federal Register, 69, 19673
- 1992, Can saliva THC levels be correlated to behavior?, p 190
- 2008 27–31, Simultaneous identification and quantification of Cannabis sativa cannabinoids and metabolites in oral fluid
- 2005, Clin Chem Lab Med, 43, 1377
- 2005 17–21, Saliva/plasma ratios of cocaine, ecgonine methyl ester and benzoylecgonine following controlled cocaine administration
- 2007 27–30, Toxicological analyses in the DRUID epidemiological studies: analytical methods, target analytes and analytical cut-offs
- 2007, Ther Drug Monit, 29, 493
- 2005, J Forensic Sci, 50, 928
- 2005 11, Monitoring of ecstasy (MDMA) and three metabolites in oral fluid
- 2005 2, Positive ion chemical ionization and gas chromatography/quadrupole mass spectrometry for confirmation and quantitation of benzoylecgonine in oral fluid
Cited by
Sorted by citations
Items 101–200 of 378
Measuring substance use in the club setting: a feasibility study using biochemical markers
Gripenberg, J., Elgán, T. H., Wallin, E., Shaafati, M., Beck, O., & Andréasson, S. (2012) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/1747-597x-7-7 · Cited by 39
A Dilute-and-Shoot LC–MS Method for Quantitating Opioids in Oral Fluid
Enders, J. R., & McIntire, G. L. (2015) · Journal of Analytical Toxicology · doi:10.1093/jat/bkv087 · Cited by 39
Mohamed, K. M., Al-Hazmi, A. H., Alasiri, A. M., & Ali, M. E.-S. (2016) · Journal of Chromatographic Science · doi:10.1093/chromsci/bmw082 · Cited by 39
Beck, O., Sandqvist, S., Eriksen, P. B., Franck, J., & Palmskog, G. (2010) · Journal of Chromatography B · doi:10.1016/j.jchromb.2010.06.035 · Cited by 39
Opioid Concentrations in Oral Fluid and Plasma in Cancer Patients With Pain
Heiskanen, T., Langel, K., Gunnar, T., Lillsunde, P. M., & Kalso, E. A. (2014) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2014.09.004 · Cited by 38
Fluorescence‐based lateral flow assays for rapid oral fluid roadside detection of cannabis use
Plouffe, B. D., & Murthy, S. K. (2016) · Electrophoresis · doi:10.1002/elps.201600075 · Cited by 38
Drug Exposure During Pregnancy: Analytical Methods and Toxicological Findings
Concheiro, M., & Huestis, M. A. (2018) · Bioanalysis · doi:10.4155/bio-2017-0260 · Cited by 39
Self-citationDriving under the influence of drugs
Marillier, M., & Verstraete, A. (2019) · Wiley Interdisciplinary Reviews Forensic Science · doi:10.1002/wfs2.1326 · Cited by 38
Ghorbanizamani, F., Moulahoum, H., Guler, E., & Tımur, S. (2022) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2022.119627 · Cited by 38
DUID: Oral Fluid and Blood Confirmation Compared in Belgium
der Linden, T. V., Legrand, S., Silverans, P., & Verstraete, A. (2012) · Journal of Analytical Toxicology · doi:10.1093/jat/bks038 · Cited by 37
Nanomechanical Recognition ofN-Methylammonium Salts
Dionisio, M., Oliviero, G., Menozzi, D., Federici, S., Yebeutchou, R. M., Schmidtchen, F. P., Dalcanale, E., & Bergese, P. (2012) · Journal of the American Chemical Society · doi:10.1021/ja210567k · Cited by 37
García, Y., Smolińska-Kempisty, K., Pereira, E. D., Piletska, E. V., & Piletsky, S. A. (2017) · Analytical Methods · doi:10.1039/c7ay01523b · Cited by 37
Tang, M. H. Y., Ching, C., Poon, S., Chan, S. S. S., Ng, W.-Y., Lam, M. W. C., Wong, C. K., Pao, R., Lau, A., & Mak, T. W. L. (2018) · Forensic Science International · doi:10.1016/j.forsciint.2018.03.004 · Cited by 37
The detection of flunitrazepam in beverages using portable Raman spectroscopy
Ali, E. M. A., & Edwards, H. G. M. (2016) · Drug Testing and Analysis · doi:10.1002/dta.1969 · Cited by 37
Milman, G., Schwope, D. M., Schwilke, E. W., Darwin, W. D., Kelly, D. L., Goodwin, R. S., Gorelick, D. A., & Huestis, M. A. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2011.169490 · Cited by 36
Self-citationSpectroscopic Trends for the Determination of Illicit Drugs in Oral Fluid
D’Elia, V., Montalvo, G., & García‐Ruiz, C. (2015) · Applied Spectroscopy Reviews · doi:10.1080/05704928.2015.1075206 · Cited by 36
Yonamine, M., Sanches, L. R., Paranhos, B. A. P. B., de Almeida, R. M., Andreuccetti, G., & Leyton, V. (2013) · Traffic Injury Prevention · doi:10.1080/15389588.2012.696222 · Cited by 36
Potential And Limitations of Alternative Specimens in Doping Control
Thieme, D. (2012) · Bioanalysis · doi:10.4155/bio.12.150 · Cited by 35
Illicit Drugs in Oral Fluid: Evaluation of Two Collection Devices
Cohier, C., Mégarbane, B., & Roussel, O. (2016) · Journal of Analytical Toxicology · doi:10.1093/jat/bkw100 · Cited by 35
Reinstadler, V., Lierheimer, S., Böettcher, M., & Oberacher, H. (2018) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-018-1504-x · Cited by 35
Kahl, J. M. M., da Cunha, K. F., Rodrigues, L. C., Chinaglia, K. D. O., Oliveira, K. D., & Costa, J. L. (2021) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2021.113928 · Cited by 35
Appropriate Use of Drug Testing in Clinical Addiction Medicine
Baxter, L., Brown, L. M., Jacobs, W., Kleinschmidt, K., Kushner, M., Nelson, L., Sprintz, M., Terplan, M., Warner, E., Wiegand, T., et al. (2017) · Journal of addiction medicine · doi:10.1097/adm.0000000000000322 · Cited by 149
van der Heide, S., Calavia, P. G., Hardwick, S., Hudson, S. C., Wolff, K., & Russell, D. A. (2015) · Forensic Science International · doi:10.1016/j.forsciint.2015.02.008 · Cited by 34
An overview of sample preparation in forensic toxicology
Botch‐Jones, S., McGowan, C. K., Boyle, S., Ke, Y., Chan, C. H. M., & Hwang, H. (2021) · Wiley Interdisciplinary Reviews Forensic Science · doi:10.1002/wfs2.1436 · Cited by 34
Kiang, T. K. L., & Ensom, M. H. H. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0321-z · Cited by 33
Michailidou, E. Z., Tzimagiorgis, G., Chatzopoulou, F. M., Vahtsevanos, K., Antoniadis, K., Kouidou, S., Markopoulos, A. K., & Antoniades, D. (2016) · Cancer Epidemiology · doi:10.1016/j.canep.2016.04.011 · Cited by 33
Workplace drug testing, different matrices different objectives
Tsanaclis, L., Wicks, J. F. C., & Chasin, A. A. D. M. (2012) · Drug Testing and Analysis · doi:10.1002/dta.399 · Cited by 33
Ellefsen, K. N., Concheiro, M., Beck, O., Gorelick, D. A., Pirard, S., & Huestis, M. A. (2014) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-014-8051-x · Cited by 32
Self-citationKneisel, S., Speck, M., Moosmann, B., & Auwärter, V. (2013) · Drug Testing and Analysis · doi:10.1002/dta.1497 · Cited by 32
Vidal, J. C., Bertolín, J. R., Bonel, L., Asturias, L., Arcos‐Martínez, M. J., & Castillo, J. R. (2016) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2016.03.004 · Cited by 32
Munoz, E. M., Lorenzo-Abalde, S., González‐Fernández, Á., Quintela, O., López‐Rivadulla, M., & Riguera, R. (2011) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2011.04.056 · Cited by 32
Oral Fluid Drug Analysis in The Age of New Psychoactive Substances
Øiestad, E. L., Øiestad, Å. M. L., Gjelstad, A., & Karinen, R. (2016) · Bioanalysis · doi:10.4155/bio-2015-0027 · Cited by 31
Practical Technology for Expanding and Improving Substance Use Disorder Treatment
Sweeney, M. M., Holtyn, A. F., Stitzer, M. L., & Gastfriend, D. R. (2022) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2022.05.006 · Cited by 34
L⊘d⊘en, C. P., Eibak, L. E. E., Rasmussen, K. E., Pedersen‐Bjergaard, S., Andersen, T., & Gjelstad, A. (2013) · Bioanalysis · doi:10.4155/bio.12.315 · Cited by 31
Milman, G., Barnes, A. J., Schwope, D. M., Schwilke, E. W., Goodwin, R. S., Kelly, D. L., Gorelick, D. A., & Huestis, M. A. (2011) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-011-5066-4 · Cited by 31
Self-citationEvaluation of Dräger DrugTest 5000 in a Naturalistic Setting
Gjerde, H., Clausen, G. B., Andreassen, E., & Furuhaugen, H. (2018) · Journal of Analytical Toxicology · doi:10.1093/jat/bky003 · Cited by 31
Samano, K. L., Clouette, R. E., Rowland, B. J., & Sample, R. H. B. (2015) · Journal of Analytical Toxicology · doi:10.1093/jat/bkv081 · Cited by 30
Ellefsen, K. N., Concheiro, M., Pirard, S., Gorelick, D. A., & Huestis, M. A. (2016) · Forensic Science International · doi:10.1016/j.forsciint.2016.01.013 · Cited by 30
Self-citationKrotulski, A. J., Mohr, A. L. A., Friscia, M., & Logan, B. K. (2017) · Journal of Analytical Toxicology · doi:10.1093/jat/bkx105 · Cited by 30
Sousa, D. V. M., Pereira, F. V., Nascentes, C. C., Moreira, J. S., Boratto, V. H. M., & Orlando, R. M. (2019) · Talanta · doi:10.1016/j.talanta.2019.120353 · Cited by 30
Quantitative Measurement of XLR11 and UR-144 in Oral Fluid by LC–MS-MS
Amaratunga, P., Thomas, C., Lemberg, B. L., & Lemberg, D. (2014) · Journal of Analytical Toxicology · doi:10.1093/jat/bku040 · Cited by 30
Rago, M. D., Chu, M., Rodda, L. N., Jenkins, E., Kotsos, A., & Gerostamoulos, D. (2016) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-016-9458-3 · Cited by 30
Recent advances of drugs monitoring in oral fluid and comparison with blood
Casati, S., Binda, M., Dongiovanni, P., Meroni, M., D’Amato, A., Roda, G., Orioli, M., FABBRO, M. D., & Tartaglia, G. M. (2023) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2023-0343 · Cited by 29
Influence of Sampling on the Determination of Warfarin and Warfarin Alcohols in Oral Fluid
Lomonaco, T., Ghimenti, S., Piga, I., Biagini, D., Onor, M., Fuoco, R., & Francesco, F. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114430 · Cited by 29
Lee, D., Karschner, E. L., Milman, G., Barnes, A. J., Goodwin, R. S., & Huestis, M. A. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.10.011 · Cited by 29
Self-citationLee, C., Su, H., Cai, Y.-D., Wu, M., Wu, D.-C., & Shiea, J. (2017) · Mass Spectrometry · doi:10.5702/massspectrometry.s0056 · Cited by 29
Moulahoum, H., Ghorbanizamani, F., & Tımur, S. (2021) · Microchimica Acta · doi:10.1007/s00604-021-05062-y · Cited by 29
Christodoulides, N. J., Garza, R. D. L., Simmons, G. W., McRae, M. P., Wong, J., Newton, T. F., Smith, R., Mahoney, J. J., Hohenstein, J., Gomez, S., et al. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.04.026 · Cited by 29
Scherer, J. N., Fiorentin, T. R., Borille, B. T., Pasa, G. G., Sousa, T. V., DIEMEN, L. V., Limberger, R. P., & Pechansky, F. (2017) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2017.05.021 · Cited by 28
Zeng, H., Agyapong, D. A. Y., Li, C., Zhao, R., Yang, H., Wu, C., Jiang, Y., & Liu, Y. (2015) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2015.06.062 · Cited by 28
Oral Fluid vs. Urine Analysis to Monitor Synthetic Cannabinoids and Classic Drugs Recent Exposure
Blandino, V., Wetzel, J., Kim, J., Haxhi, P., Curtis, R., & Concheiro, M. (2017) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201018666171122113934 · Cited by 27
Marsot, A., Audebert, C., Attolini, L., Lacarelle, B., Micallef, J., & Blin, O. J. (2016) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3f31d · Cited by 27
Hsu, Y.-C., Chen, B.-G., Yang, S.-C., Wang, Y., Huang, S.-P., Huang, M., Chen, T., Liu, H.-C., Lin, D., Liu, R. H., et al. (2012) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-012-6460-2 · Cited by 26
Thieme, D., Rautenberg, C., Grosse, J., & Schönfelder, M. (2013) · Drug Testing and Analysis · doi:10.1002/dta.1536 · Cited by 26
Lee, D., Vandrey, R. G., Milman, G., Bergamaschi, M. M., Mendu, D. R., Murray, J. A., Barnes, A. J., & Huestis, M. A. (2013) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-013-7159-8 · Cited by 26
Self-citationDetection of drugs in simultaneously collected samples of oral fluid and blood
Bakke, E., Høiseth, G., Arnestad, M., & Gjerde, H. (2019) · Journal of Analytical Toxicology · doi:10.1093/jat/bky079 · Cited by 25
Determination of Illicit Drugs in Urine and Plasma by Micro-SPE Followed by HPLC–MS/MS
Napoletano, S., Montesano, C., Compagnone, D., Curini, R., D'Ascenzo, G., Roccia, C., & Sergi, M. (2011) · Chromatographia · doi:10.1007/s10337-011-2156-6 · Cited by 25
Evaluation of Oral Fluid as a Specimen for DUID
Veitenheimer, A. M., & Wagner, J. R. (2017) · Journal of Analytical Toxicology · doi:10.1093/jat/bkx036 · Cited by 24
Indirect Competitive Assays on DVD for Direct Multiplex Detection of Drugs of Abuse in Oral Fluids
Zhang, L., Li, X., Li, Y., Shi, X., & Yu, H. (2014) · Analytical Chemistry · doi:10.1021/ac5040715 · Cited by 24
Impact of oral fluid collection device on cannabinoid stability following smoked cannabis
Anizan, S., Bergamaschi, M. M., Barnes, A. J., Milman, G., Desrosiers, N. A., Lee, D., Gorelick, D. A., & Huestis, M. A. (2014) · Drug Testing and Analysis · doi:10.1002/dta.1688 · Cited by 23
Self-citationVincenti, F., Montesano, C., Pirau, S., Gregori, A., Rosa, F. D., Curini, R., & Sergi, M. (2021) · Molecules · doi:10.3390/molecules26195870 · Cited by 23
Shin, S. S., Borg, D., & Stripp, R. (2020) · Journal of Analytical Toxicology · doi:10.1093/jat/bkz117 · Cited by 23
Cone, E. J. (2011) · Forensic Science International · doi:10.1016/j.forsciint.2011.01.046 · Cited by 23
Wong, S. H., Happy, C., Blinka, D. D., Gock, S. B., Jentzen, J. M., Hon., J. D., Coleman, H., Jortani, S. A., Lucire, Y., Morris-Kukoski, C. L., et al. (2010) · Pharmacogenomics · doi:10.2217/pgs.10.63 · Cited by 23
A rapid assay provides on-site quantification of tetrahydrocannabinol in oral fluid
Yu, H., Lee, H.-Y., Cheong, J., Woo, S. W., Oh, H.-K., Oh, H.-K., Lee, J.-H., Zheng, H., Castro, C. M., Yoo, Y., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abe2352 · Cited by 22
Wille, S. M. R., Fernández, M. D. M. R., Samyn, N., & Boeck, G. D. (2010) · Bioanalysis · doi:10.4155/bio.10.29 · Cited by 22
Labbe, A. K., Greene, C., Bergman, B. G., Hoeppner, B. B., & Kelly, J. F. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.07.021 · Cited by 22
Parkin, M. C., Longmoore, A., Turfus, S. C., Braithwaite, R. A., Cowan, D., Elliott, S. P., & Kicman, A. T. (2012) · Journal of Chromatography A · doi:10.1016/j.chroma.2012.12.019 · Cited by 22
MDMA and Metabolite Disposition in Expectorated Oral Fluid After Controlled Oral MDMA Administration
Barnes, A. J., Scheidweiler, K. B., Kolbrich, E. A., Gorelick, D. A., Goodwin, R. S., & Huestis, M. A. (2011) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e3182281975 · Cited by 22
Self-citationGeorge, R., Lobb, M., Haywood, A., Khan, S. A., Hardy, J. R., Good, P. D., Hennig, S., & Norris, R. L. G. (2015) · Talanta · doi:10.1016/j.talanta.2015.11.044 · Cited by 22
Saar‐Reismaa, P., Brilla, C.-A., Leiman, K., Kaljurand, M., Vaher, M., Kulp, M., & Mazina-Šinkar, J. (2019) · Talanta · doi:10.1016/j.talanta.2019.120662 · Cited by 22
Current state-of-the-art approaches for mass spectrometry in clinical toxicology: an overview
Peters, F. T., & Wissenbach, D. (2023) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2023.2252324 · Cited by 21
Scheidweiler, K. B., Himes, S. K., Chen, X., Liu, H., & Huestis, M. A. (2013) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-013-7027-6 · Cited by 21
Self-citationEllefsen, K. N., Concheiro, M., Pirard, S., Gorelick, D. A., & Huestis, M. A. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.04.004 · Cited by 21
Self-citationGorziza, R. P., Cox, J., Limberger, R. P., & Arroyo, L. (2020) · Forensic Chemistry · doi:10.1016/j.forc.2020.100254 · Cited by 21
Calò, L., Anzillotti, L., Maccari, C., Cecchi, R., & Andreoli, R. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00439 · Cited by 21
Arantes, A. C. F., da Cunha, K. F., Cardoso, M. S., Oliveira, K. D., & Costa, J. L. (2020) · Forensic Toxicology · doi:10.1007/s11419-020-00561-8 · Cited by 21
Conductive vial electromembrane extraction of opioids from oral fluid
Skaalvik, T. G., Zhou, C., Øiestad, E. L., Hegstad, S., Trones, R., & Pedersen‐Bjergaard, S. (2023) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-023-04807-3 · Cited by 21
Beck, O., Stephanson, N. N., Sandqvist, S., & Franck, J. (2014) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000046 · Cited by 20
Nordal, K., Øiestad, E. L., Enger, A., Christophersen, A. S., & Vindenes, V. (2014) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000174 · Cited by 20
Hardy, J. R., Norris, R. L. G., Anderson, H., O’Shea, A., & Charles, B. G. (2011) · Supportive Care in Cancer · doi:10.1007/s00520-011-1147-3 · Cited by 19
Melanson, S. E. F., Griggs, D. A., Bixho, I., Khaliq, T., & Flood, J. G. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.01.027 · Cited by 19
Pharmacokinetic properties of the synthetic cannabinoid JWH‐018 in oral fluid after inhalation
Toennes, S. W., Geraths, A., Pogoda, W., Paulke, A., Wunder, C., Theunissen, E. L., & Ramaekers, J. G. (2017) · Drug Testing and Analysis · doi:10.1002/dta.2310 · Cited by 19
Li, H., Vinther, J., & Gothelf, K. V. (2019) · Advanced Science · doi:10.1002/advs.201802051 · Cited by 19
Newmeyer, M. N., Concheiro, M., Costa, J. L., Flegel, R. R., Gorelick, D. A., & Huestis, M. A. (2015) · Drug Testing and Analysis · doi:10.1002/dta.1784 · Cited by 19
Self-citationCatalytic lateral flow immunoassays (cLFIA™): Amplified signal in a self-contained assay format
Mulvaney, S. P., Kidwell, D. A., Lanese, J. N., Lopez, R. P., Sumera, M. E., & Wei, E. (2020) · Sensing and Bio-Sensing Research · doi:10.1016/j.sbsr.2020.100390 · Cited by 18
Whether drug detection in urine and oral fluid is similar? A systematic review
Martini, M. B. A., Batista, T. B. D., Henn, I. W., de Souza, P. T. D. R., Vieira, A. R., & Azevedo‐Alanis, L. R. (2020) · Critical Reviews in Toxicology · doi:10.1080/10408444.2020.1751062 · Cited by 20
Dried Blood Spot in Toxicology: Current Knowledge
Niemiec, A. (2021) · Separations · doi:10.3390/separations8090145 · Cited by 17
An overview of quantifying and screening drugs of abuse in biological samples: Past and present
Fernández, C., & Banks, C. E. (2011) · Analytical Methods · doi:10.1039/c1ay05057e · Cited by 17
Marchei, E., Farré, M., Lozano, R. P., García‐Algar, Ó., Pellegrini, M., Pacifici, R., & Pichini, S. (2010) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e3181e4e6f8 · Cited by 17
Influence of Ethanol on the Pharmacokinetic Properties of 9-Tetrahydrocannabinol in Oral Fluid
Toennes, S. W., Schneider, K., Wunder, C., Kauert, G. F., Moeller, M. R., Theunissen, E. L., & Ramaekers, J. G. (2013) · Journal of Analytical Toxicology · doi:10.1093/jat/bkt002 · Cited by 17
Flood, J. G., Khaliq, T., Bishop, K. A., & Griggs, D. A. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2015.251066 · Cited by 17
Polet, M., Wilde, L. D., Renterghem, P. V., Gansbeke, W. V., & Eenoo, P. V. (2017) · Analytica Chimica Acta · doi:10.1016/j.aca.2017.11.015 · Cited by 17
Huestis, M. A. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.134551 · Cited by 17
Self-citationAptamer‐based fluorescent sensor for highly sensitive detection of methamphetamine
Wang, Y., Wang, Z., Tong, Y., Zhang, D., Yun, K., Yan, J., & Niu, W. (2024) · Luminescence · doi:10.1002/bio.4687 · Cited by 16
Hartman, R. L., Anizan, S., Jang, M., Brown, T. L., Yun, K., Gorelick, D. A., Milavetz, G., Spurgin, A. L., Gaffney, G., & Huestis, M. A. (2015) · Forensic Toxicology · doi:10.1007/s11419-015-0269-6 · Cited by 16
Self-citationCocaine and benzoylecgonine oral fluid on‐site screening and confirmation
Ellefsen, K. N., Concheiro, M., Pirard, S., Gorelick, D. A., & Huestis, M. A. (2016) · Drug Testing and Analysis · doi:10.1002/dta.1966 · Cited by 16
Self-citationZheng, Y., Sparve, E., & Bergström, M. (2017) · Drug Testing and Analysis · doi:10.1002/dta.2325 · Cited by 16
Ransohoff, J. R., Petrides, A. K., Piscitello, G. J., Flood, J. G., & Melanson, S. E. F. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.06.015 · Cited by 16
Detection of 4 Benzodiazepines in Oral Fluid as Biomarker for Presence in Blood
Gjerde, H., Langel, K., Favretto, D., & Verstraete, A. (2013) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e3182a3ab42 · Cited by 15
Metadata
- Authors
- Bosker, W. M., & Huestis, M. A.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Huestis, Marilyn A
- ORCID
- Huestis, Marilyn A
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-11-01
- Volume
- 55
- Issue
- 11
- Pages
- 1910-1931
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- PMC
- PMC3165054
- OpenAlex
- W2062866182
- Cited by
- 378
- References
- 125
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 14 · 2023: 8 · 2022: 19 · 2021: 18 · 2020: 25 · 2019: 22 · 2018: 23 · 2017: 31 · 2016: 27 · 2015: 35 · 2014: 28 · 2013: 33 · 2012: 36
- FWCI
- 4.95
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Clinical Chemistry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute on Drug Abuse (ZIADA000412)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- oral fluid testing, drugs of abuse, drug testing, workplace drug testing, drug-impaired driving, cannabinoids, opioids, amphetamine, cocaine, benzodiazepines, analyte stability, immunoassay, chromatographic methods, drug monitoring
- MeSH terms
- Amphetamines, Analgesics, Opioid, Benzodiazepines, Cannabinoids, Cocaine, Humans, Saliva, Substance Abuse Detection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review